MedPath

Online LTP+CaCBT for Treating Depression in British Mothers of African/Caribbean Heritage

Not Applicable
Conditions
Postnatal Depression
Registration Number
NCT04820920
Lead Sponsor
Nottingham Trent University
Brief Summary

The pilot trial aims to test the feasibility, acceptability and cultural appropriateness of online LTP+CaCBT for treating postnatal depression and to improve the mental health and wellbeing of mothers and their children in the UK.

Detailed Description

Participants who scored 5 or above on Patient Health Questionnaire (PHQ-9) will be would be recruited and randomly assigned into one of two groups (experimental or controlled). Experimental groups will receive the online LTP+CaCBT treatment - the intervention will consist of a total of 12 group training sessions (approx. 60 minutes each). The controlled groups will receive 'placebo effects' in the form of psychoeducation involving basic discussions around mother-child relationships, childcare, child nursing related activities and general maternal discussions. Each of the two groups (both experimental and controlled) will be comprised of approximately 10 mother-child pairs per sub-group.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • 18 years and above
  • A mother with a child (0-3 years) from the African and/or Caribbean heritage
  • Able to provide full consent for their participation
  • A resident of the UK
  • Able to complete a baseline assessment
  • Score 5 or above on Patient Health Questionnaire (PHQ-9)
Exclusion Criteria
  • Less than 18 years
  • Medical disorder that would prevent participation in a clinical trial such as Tuberculosis or heart failure
  • Temporary residents are unlikely to be available for follow up
  • Active suicidal ideation or any other severe mental disorder
  • Non-residents of the UK
  • Unable to consent
  • Patients currently undergoing severe mental health treatment
  • Unable to speak the English language fluently
  • Other significant physical or learning disability

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in postnatal depression is being assessedChange is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention

Primary outcome measure would be assessed using the Edinburgh Postnatal Depression Scale

Change in postnatal anxiety is being assessedChange is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention

Primary outcome measure would be assessed using the Generalised Anxiety Disorder (GAD7) scale

Change in health is being assessedChange is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention

Primary outcome measure would be assessed using the Patient Health Questionnaire (PHQ-9)

Change in social support is being assessedChange is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention

Primary outcome measures would be assessed using the Oslo Social Support Scale

Change in health-related quality of life is being assessedChange is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention

Outcome measure would be assessed using the Health-related Quality of Life scale (EuroQoL-5 Dimensions)

Change in service satisfaction is being assessedChange is being assessed at end of intervention, at 3-months and at 6-months post-intervention

Outcome measure would be assessed using the brief Verona Service Satisfaction Scale

Change in child physio-emotional development is being assessedChange is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention

Outcome measure would be assessed using the Ages and Stages Social-Emotional Questionnaire

Change in parenting knowledge of child development is being assessedChange is being assessed from baseline, end of intervention, at 3-months and at 6-months post-intervention

Outcome measure would be assessed using the Learning through Play (LTP) Knowledge, Attitude and Practices (KAP) Questionnaire

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Nottingham Trent University

🇬🇧

Nottingham, England, United Kingdom

Nottingham Trent University
🇬🇧Nottingham, England, United Kingdom
Dung Jidong, PhD
Contact
115 84 86478
dung.jidong@ntu.ac.uk

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.